4.6 Editorial Material

Intensive care medicine in 2050: nanotechnology. Emerging technologies and approaches and their impact on critical care

Journal

INTENSIVE CARE MEDICINE
Volume 44, Issue 8, Pages 1299-1301

Publisher

SPRINGER
DOI: 10.1007/s00134-017-5002-y

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Critical Care Medicine

A differential therapeutic consideration for use of corticosteroids according to established COVID-19 clinical phenotypes in critically ill patients

G. Moreno, M. Ruiz-Botella, I Martin-Loeches, J. Gomez Alvarez, M. Jimenez Herrera, M. Bodi, F. Armestar, A. Marques Parra, A. Estella, S. Trefler, R. Jorge Garcia, J. Murcia Paya, P. Vidal Cortes, E. Diaz, R. Ferrer, A. Albaya-Moreno, L. Socias-Crespi, J. M. Bonell Goytisolo, S. Sancho Chinesta, A. Loza, L. Forcelledo Espina, J. C. Pozo Laderas, M. DeAlba-Aparicio, L. Sanchez Montori, I Vallverdu Perapoch, V Hidalgo, V Fraile Gutierrez, A. M. Casamitjana Ortega, F. Martin Serrano, M. Nieto, M. Blasco Cortes, J. Marin-Corral, J. Sole-Violan, A. Rodriguez

Summary: This study aimed to determine the association between corticosteroid use and ICU mortality in both the whole population and pre-specified clinical phenotypes. The results showed that corticosteroids were not associated with ICU mortality in the overall population, but they may have a protective effect in patients with the highest inflammatory levels.

MEDICINA INTENSIVA (2023)

Editorial Material Critical Care Medicine

Bronchoscopy for diagnosis of ventilator-associated pneumonia

Ignacio Martin-Loeches, Jean Chastre, Richard G. Wunderink

INTENSIVE CARE MEDICINE (2023)

Editorial Material Critical Care Medicine

Multidrug-resistant bacteria in the grey shades of immunosuppression

Lene Russell, Frederic Pene, Ignacio Martin-Loeches

INTENSIVE CARE MEDICINE (2023)

Article Infectious Diseases

Sepsis and antibiotics: When should we deploy a parachute?

Sharon Einav, Marc Leone, Ignacio Martin-Loeches

Summary: Guidelines recommend early administration of antimicrobial therapy in sepsis and septic shock, based on observational studies suggesting improved outcomes. However, front-line physicians face pressure to quickly decide on antibiotic use in uncertain sepsis cases. Overuse of antibiotics contributes to the emergence of multidrug-resistant bacteria, and this article discusses the situation of physicians criticized for unnecessary or delayed antibiotic use and offers options to assist bedside decision-making.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2023)

Article Infectious Diseases

Antimicrobial consumption and drug utilization patterns among COVID-19 and non-COVID-19 patients

Bianca B. P. Antunes, Amanda A. B. Silva, Patricia H. C. Nunes, Ignacio Martin-Loeches, Pedro Kurtz, Silvio Hamacher, Fernando A. Bozza

Summary: The objective of this study was to compare the differences in antimicrobial use between COVID-19 and non-COVID-19 patients, and to compare two commonly used metrics for antimicrobial use: Defined Daily Dose (DDD) and Days of Therapy (DOT). The study found that COVID-19 patients had a higher use of broad-spectrum antimicrobials in the ICU, and overall, the DDD metric overestimated antimicrobial use compared with the DOT metric.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2023)

Review Infectious Diseases

The Role of Biomarkers in Influenza and COVID-19 Community-Acquired Pneumonia in Adults

Raquel Carbonell, Gerard Moreno, Ignacio Martin-Loeches, Maria Bodi, Alejandro Rodriguez

Summary: Pneumonia is a significant global problem, with viruses being a common cause and mixed viral and bacterial pneumonia posing a risk for severe disease. Biomarkers, such as procalcitonin (PCT) and C-reactive protein (CRP), can provide valuable information for early diagnosis and prognosis. This review analyzes the available evidence and provides recommendations for the use of biomarkers in influenza and SARS-CoV-2 pneumonia. The authors propose a practical PCT algorithm for guiding antibiotic initiation in these cases.

ANTIBIOTICS-BASEL (2023)

Article Medicine, General & Internal

Invasive Pulmonary Aspergillosis: Not Only a Disease Affecting Immunosuppressed Patients

Rafael Zaragoza, Jordi Sole-Violan, Rachel Cusack, Alejandro Rodriguez, Luis Felipe Reyes, Ignacio Martin-Loeches

Summary: Fungal infections in Intensive Care Units (ICUs) have become a common threat due to changes in patient profiles and increased use of immunomodulatory agents. The use of corticosteroids is associated with a higher incidence of Invasive Pulmonary Aspergillosis (IPA) in critically ill patients. Different diagnosis criteria and more aggressive acquisition of samples through invasive respiratory examinations contribute to the complexity of understanding current IPA data.

DIAGNOSTICS (2023)

Article Anesthesiology

Timing of intubation and ICU mortality in COVID-19 patients: a retrospective analysis of 4198 critically ill patients during the first and second waves

Sara Manrique, Laura Claverias, Monica Magret, Joan Ramon Masclans, Maria Bodi, Sandra Trefler, Laura Canadell, Emili Diaz, Jordi Sole-Violan, Elena Bisbal-Andres, Ruth Gonzalez Natera, Antonio Albaya Moreno, Montserrat Vallverdu, Juan Carlos Ballesteros, Lorenzo Socias, Federico Gordo Vidal, Susana Sancho, Ignacio Martin-Loeches, Alejandro Rodriguez

Summary: This study aimed to determine the optimal time for intubation in COVID-19 patients and found that early intubation (within 24 hours) was associated with a decreased risk of mortality.

BMC ANESTHESIOLOGY (2023)

Article Medicine, General & Internal

Antimicrobial Stewardship for Ventilator Associated Pneumonia in Intensive Care (the ASPIC trial): study protocol for a randomised controlled trial

Arnaud Foucrier, Antoine Roquilly, Delphine Bachelet, Ignacio Martin-Loeches, Adrien Bougle, Jean-Francois Timsit, Philippe Montravers, Jean-Ralph Zahar, Philippine Eloy, Emmanuel Weiss, ASPIC Study Grp

Summary: This study aims to demonstrate that reducing the duration of antibiotic therapy for ventilator-associated pneumonia (VAP) based on clinical assessment is safe and can lead to changes in practice as part of a personalized therapeutic approach, by reducing exposure to antibiotics and their side effects.

BMJ OPEN (2023)

Article Critical Care Medicine

Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trial

Ignacio Martin-Loeches, Andrew F. Shorr, Richard G. Wunderink, Marin H. Kollef, Jean-Francois Timsit, Brian Yu, Jennifer A. Huntington, Erin Jensen, Christopher J. Bruno

Summary: This study compared the treatment outcomes of two drugs in critically ill patients with ventilated hospital-acquired/ventilator-associated bacterial pneumonia. The results showed that ceftolozane/tazobactam was as effective as meropenem in treating this condition, indicating that both agents can be used in critically ill patients.

ANNALS OF INTENSIVE CARE (2023)

Review Anesthesiology

Multimodal strategy to counteract vasodilation in septic shock

Marc Leone, Sharon Einav, Elio Antonucci, Francois Depret, Ines Lakbar, Ignacio Martin-Loeches, Patrick M. Wieruszewski, Sheila Nainan Myatra, Ashish K. Khanna

Summary: Early initiation of multimodal treatment strategy for vasopressors in septic shock is important to reduce delays in organ perfusion and mitigate side effects. This review summarizes the pathophysiology of vasodilation, physiological response, and different drugs used in this situation. Norepinephrine is usually the first-line vasopressor, but sparing it through the use of adrenergic, vasopressinergic, and renin-angiotensin systems, as well as endothelial reactivity optimization with methylene blue, is discussed. A blueprint for future studies on vasopressor selection and timing in septic shock is outlined.

ANAESTHESIA CRITICAL CARE & PAIN MEDICINE (2023)

Review Critical Care Medicine

Research priorities for therapeutic plasma exchange in critically ill patients

Sascha David, Lene Russell, Pedro Castro, Andry van de Louw, Lara Zafrani, Tasneem D. Pirani, Nathan Nielsen, Eric L. Mariotte, Bruno T. Ferreyro, Jan Kielstein, Luca C. Montini, Anne Brignier, Matthias Kochanek, Joan Cid, Chiara Robba, Ignacio Martin-Loeches, Marlies P. Ostermann, Nicole Juffermans

Summary: Therapeutic plasma exchange (TPE) is a method of removing pathological factors or replenishing deficient factors by separating plasma from blood cells. Despite a good theoretical rationale and biological plausibility, the use of TPE in the ICU setting has not been extensively studied. A group of global experts utilized the Delphi method to identify key research questions and gaps in knowledge related to TPE in critically ill patients, aiming to stimulate future research and clinical applications.

INTENSIVE CARE MEDICINE EXPERIMENTAL (2023)

Article Infectious Diseases

Imipenem/cilastatin/relebactam efficacy, safety and probability of target attainment in adults with hospital-acquired or ventilator-associated bacterial pneumonia among patients with baseline renal impairment, normal renal function, and augmented renal clearance

Jason A. Roberts, David P. Nicolau, Ignacio Martin-Loeches, C. Andrew Deryke, Maria C. Losada, Jiejun Du, Munjal Patel, Matthew L. Rizk, Amanda Paschke, Luke F. Chen

Summary: The study aimed to assess the relationship between renal function and the efficacy/safety of imipenem/cilastatin/relebactam for the treatment of HABP/VABP. The results showed that the efficacy of imipenem/cilastatin/relebactam was comparable to piperacillin/tazobactam for participants with various baseline renal functions. However, for participants with normal renal function or CLCR >= 250ml/min, imipenem/cilastatin/relebactam had a higher clinical response rate.

JAC-ANTIMICROBIAL RESISTANCE (2023)

Article Biochemistry & Molecular Biology

Evaluation of the Kinetics of Pancreatic Stone Protein as a Predictor of Ventilator-Associated Pneumonia

Adrian Ceccato, Marta Camprubi-Rimblas, Lieuwe D. J. Bos, Pedro Povoa, Ignacio Martin-Loeches, Carles Forne, Aina Areny-Balaguero, Elena Campana-Duel, Luis Morales-Quinteros, Sara Quero, Paula Ramirez, Mariano Esperatti, Antoni Torres, Lluis Blanch, Antonio Artigas

Summary: The measurement and dynamics of Pancreatic Stone Protein (PSP) do not contribute to the early diagnosis of Ventilator-associated pneumonia (VAP).

BIOMEDICINES (2023)

Article Medicine, General & Internal

Antibiotic stewardship: Dead bugs do not mutate

Ignacio Martin-Loeches, Marc Leone, Sharon Einav

JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE (2023)

No Data Available